Glenn Sobotka - 14 Apr 2022 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Accounting Officer
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
14 Apr 2022
Transactions value $
$0
Form type
4
Filing time
20 Apr 2022, 16:59:36 UTC
Previous filing
12 Nov 2021
Next filing
28 Mar 2025
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +2.44K +74.82% $0.00 5.7K 14 Apr 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Award $0 +8.03K $0.00 8.03K 14 Apr 2022 Common Stock 8.03K $23.07 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment.
F2 Includes restricted stock units.
F3 Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment.